返回新聞

新聞來自 Uni-Bio Science Group Limited

Uni-Bio Science Group
#Finance #Science
28 August 2023

Uni-Bio Science Group Announces 2023 Interim Results

Uni-Bio Science Group Limited
#Business #Healthcare
27 March 2023

Uni-Bio Science Group Limited Announces 2022 Annual Results

#Pharma #Business
29 August 2022

Uni-Bio Science Group Limited: 2022 Interim Results

Uni-Bio Science Group Limited
#Science #Medical
29 June 2022

Marketing application of BOGUTAI® (teriparatide injection) has been officially accepted by the China National Medical Products Administration (NMPA)

Uni-Bio Science Group Limited
#Business & Finance #Business
22 March 2022

Uni-Bio Science Group Limited：2021 Annual Results

#Business
27 August 2021

Uni-Bio Science Group: 2021 Interim Results

#Business
30 March 2021

Uni-Bio Science Group: 2020 Annual Results

#Business
10 March 2021

Uni-Bio Science Group and DotBio Announce Partnership to Co-Develop multi-specific DotBodies for people with retinal diseases

#Medical
16 December 2020

Uni-Bio Science Group Receives BE Certification for PINUP® (Voriconazole Tablets) by the NMPA

#Medical
16 December 2020

Uni-Bio Science Group: The National Medical Products Administration Granted Marketing Approval for BOSHUTAI® (Acarbose Tablets) in China

#Business
18 September 2020

VOLUNTARY ANNOUNCEMENT: Uni-GLP Development in Treatment of COVID-19 and Other Indications

#Business
04 September 2020

Uni-Bio Science Group Receives IND Approval for Uni-PTH Liquid Injection by the National Medical Products Administration

#Business
28 August 2020

Uni-Bio Science Group Announces 2020 Interim Results

#Business
15 May 2020

Uni-Bio Science Group and Medlink Builds Strategic Partnership Expansion of Value Chain towards Pharmaceutical E-commerce

#Business
05 May 2020

Collaboration between Uni-Bio Science Group and Swiss company Ypsomed to jointly develop 2nd generation diabetes and osteoporosis products

立即聯繫 Media OutReach

立即聯繫我們